Generics - Men's Health

Filter

Current filters:

Men's Health

Popular Filters

Pfizer tackles Torrent over generic Viagra

Pfizer tackles Torrent over generic Viagra

19-03-2014

US pharma giant Pfizer is taking legal action against Indian drugmaker Torrent Pharmaceuticals to stop…

GenericsIndiaLegalMen's HealthPfizerPharmaceuticalTorrent PharmaceuticalsUSAViagra

Actavis confirms challenge of Lilly’s Axiron patent

Actavis confirms challenge of Lilly’s Axiron patent

14-11-2013

US generics major Actavis confirms that it has filed an Abbreviated New Drug Application with the US…

ActavisAxironEli LillyGenericsLegalMen's HealthNorth AmericaPatentsRegulation

BPH drug doesn't increase risk of death, but does save men from prostate cancer

15-08-2013

A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research…

finasterideGenericsMen's HealthMerck & CoOncologyPharmaceuticalProscarResearch

Teva and Actavis debut generic Viagra in Europe

24-06-2013

The patent on Viagra (sildenafil) expired last Friday (June 21) in the UK and some other European countries,…

ActavisEuropeGenericsMarkets & MarketingMen's HealthReproductivesildenafilTeva Pharmaceutical IndustriesViagra

Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent

19-06-2013

USA-based Actavis (NYSE: ACT), itself predominantly a generic drug marketer, and Japan's Kissei Pharmaceutical…

ActavisGenericsHetero GroupMen's HealthNorth AmericaNovartisPatentsPharmaceuticalRapaflo CapsulesSandoz

Actavis confirms patent challenge to Endo's Fortesta

04-03-2013

Generics drug giant Actavis (NYSE: ACT, formerly trading as Watson) has confirmed filing an Abbreviated…

ActavisEndo PharmaceuticalsFortestaGenericsMen's HealthNorth AmericaPatentsRegulation

Canada's Supreme Court paves way for generic Viagra

09-11-2012

There was disappointing news for global pharma behemoth Pfizer (NYSE: PFE) yesterday, when the Canadian…

GenericsLegalMen's HealthNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesViagra

FTC seeks US Supreme Court review in AndroGel "pay-for-delay" case

08-10-2012

At the request of the US Federal Trade Commission, the Solicitor General of the USA petitioned the country's…

Abbott LaboratoriesAndroGelGenericsLegalMen's HealthNorth AmericaPatentsPharmaceuticalSolvayWatson Pharmaceuticals

Back to top